These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6243373)

  • 1. Neurological dysfunction of the bladder in workers exposed to dimethylaminopropionitrile.
    Kreiss K; Wegman DH; Niles CA; Siroky MB; Krane RJ; Feldman RG
    JAMA; 1980 Feb 22-29; 243(8):741-5. PubMed ID: 6243373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epidemic of urinary retention caused by dimethylaminopropionitrile.
    Keogh JP; Pestronk A; Wertheimer D; Moreland R
    JAMA; 1980 Feb 22-29; 243(8):746-9. PubMed ID: 6243374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up studies of workers with bladder neuropathy caused by exposure to dimethylaminopropionitrile.
    Baker EL; Christiani DC; Wegman DH; Siroky M; Niles CA; Feldman RG
    Scand J Work Environ Health; 1981; 7 Suppl 4():54-9. PubMed ID: 7330630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical syndromes in occupational medicine: dimethylaminopropionitrile.
    Keogh JP
    Am J Ind Med; 1983; 4(3):479-89. PubMed ID: 6846342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical epidemiology of occupational neurotoxic disease.
    Landrigan PJ; Kreiss K; Xintaras C; Feldman RG; Heath CW
    Neurobehav Toxicol; 1980; 2(1):43-8. PubMed ID: 6160406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of urotoxic effects of N,N'-dimethylaminopropionitrile in rats and mice. 1. Biochemical and morphologic characterization of the injury and its relationship to metabolism.
    Mumtaz MM; Farooqui MY; Ghanayem BI; Rajaraman S; Frankenberg L; Ahmed AE
    J Toxicol Environ Health; 1991 May; 33(1):1-17. PubMed ID: 2033640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupationally related neurologic abnormalities--Massachusetts.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Aug; 30(30):265-6. PubMed ID: 6790924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morbidity study of employees exposed to dimethylaminopropionitrile].
    Deckert H; Thiess AM; Mercker HJ
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 May; 32(5):181-4. PubMed ID: 7113493
    [No Abstract]   [Full Text] [Related]  

  • 9. NIAX catalyst ESN: subchronic neuropharmacology and neurotoxicology.
    McKelvy JA; Turney RA
    Drug Chem Toxicol; 1979; 2(3):223-36. PubMed ID: 546624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of monoamine oxidase in aminopropionitrile-induced neurotoxicity.
    Wilmarth KR; Froines JR
    J Toxicol Environ Health; 1991 Apr; 32(4):415-27. PubMed ID: 2016753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The incidence of neurotoxic complications in polyurethane production].
    Müller D; Selmer E; Koch RD
    Z Gesamte Hyg; 1989 Jul; 35(7):420-1. PubMed ID: 2800650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urotoxic effects of N,N'-dimethylaminopropionitrile. 2. In vivo and in vitro metabolism.
    Mumtaz MM; Farooqui MY; Ghanayem BI; Ahmed AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):61-9. PubMed ID: 1871772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute urinary bladder toxicity of a polyurethane foam catalyst mixture: a possible new target organ for propionitrile derivative.
    Jaeger RJ; Plugge H; Szabo S
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):555-62. PubMed ID: 7462919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.
    Sakakibara R; Uchiyama T; Arai K; Yamanishi T; Hattori T
    J Neurol Sci; 2004 Mar; 218(1-2):67-72. PubMed ID: 14759635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurologic dysfunction of the urinary bladder in the manufacture of polyurethane].
    Beritić T
    Arh Hig Rada Toksikol; 1980 Dec; 31(4):357-9. PubMed ID: 7259525
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occupational diseases in workers engaged into foamed polyurethane production].
    Pokrovskaia EA; Antoniuzhenko VA; Volkova ID; Ashirova SA
    Med Tr Prom Ekol; 2004; (6):42-4. PubMed ID: 15318459
    [No Abstract]   [Full Text] [Related]  

  • 17. NIOSH/OSHA joint current intelligence bulletin No. 26. NIAX catalyst ESN--a mixture of dimethylaminopropionitrile and bis [2-(dimethylamino)ethyl] ether.
    Stein HP; Casey GE; White GL; Brown PG; Rogers JD; Alexander V; Bingham E; Millar JD
    Am Ind Hyg Assoc J; 1979 Mar; 40(3):A36-42. PubMed ID: 495454
    [No Abstract]   [Full Text] [Related]  

  • 18. [The health status of workers exposed for a long time to trinitrotoluene from the neurological and psychiatric aspect].
    Hassman P; Hassmanová V; Borovská D; Preiningerová O; Hanus H; Juran J; Svĕrák J
    Cesk Neurol Neurochir; 1978 Nov; 41(6):372-9. PubMed ID: 719795
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic exposure to carbon disulfide: effects on occupationally exposed workers with special reference to the nervous system.
    Knave B; Kolmodin-Hedman B; Persson HE; Goldberg JM
    Work Environ Health; 1974; 11(1):49-58. PubMed ID: 4376319
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinical study of voiding status in multiple sclerosis patients].
    Komatsu K; Nagano K; Yokoyama O; Kawaguchi K; Hisazumi H; Hayashi S
    Hinyokika Kiyo; 1991 Jan; 37(1):25-9. PubMed ID: 2011964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.